We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus
Read MoreHide Full Article
Key Takeaways
Ryanair has surged 28.5% since its Zacks Recommendation upgrade to Outperform on April 15.
Monster Beverage jumped 15.1% in 12 weeks as part of Zacks ultra-defensive ECAP portfolio strategy.
Ulta Beauty rose 31% over 12 weeks as a holding in the Zacks Focus List portfolio.
Last Friday, the three most widely followed benchmark indexes closed a winning week. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite advanced 1.2%, 1.5% and 2.2%, respectively.
A stronger-than-expected May jobs report boosted investor confidence, pushing the S&P???500 above 6,000 for the first time since Feb. 21. Tech stocks led the charge, with Nvidia’s earnings shooting up 26% and Tesla recovering after a sharp fall linked to a public spat between Elon Musk and President Trump.
Broader optimism stemmed from easing U.S.-China trade tensions following presidential talks, helping global indices hit record highs. President Trump confirmed that he had had a very good phone call with President Xi and that trade negotiations would commence as early as this week. While tariff concerns continue to dominate proceedings, resilient data and upbeat earnings kept markets firmly in bullish territory.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Knightscope and Microbot Medical Surge Following Zacks Rank Upgrade
Shares of Knightscope, Inc. (KSCP - Free Report) have gained 142.1% (versus the S&P 500’s 20.7% increase) since it was upgraded to a Zacks Rank #2 (Buy) on April 9.
Another stock, Microbot Medical Inc. (MBOT - Free Report) , which was upgraded to a Zacks Rank #2 on April 11, has returned 57% (versus the S&P 500’s 14.2% increase) since then.
A hypothetical portfolio of Zacks Rank # 1 (Strong Buy) stocks returned -8.32% in 2025 (through May 5th) vs. -5.35% for the S&P 500 index.
This portfolio returned +22.4% in 2024, vs. +28% for the S&P 500 index and +19.9% for the equal-weight version of the S&P 500 index.
This hypothetical portfolio returned +20.65% in 2023 vs. +24.83% for the S&P 500 index and +15% for the equal-weight S&P 500 index.
The Zacks Model Portfolio - consisting of Zacks Rank #1 stocks – has outperformed the S&P index by more than 12 percentage points since 1988 (through May 5th, 2025, the Zacks # 1 Rank stocks generated an annualized average return of +23.5% vs. +11% for the S&P 500 index).
Zacks Recommendation Upgrades Ryanair and Paycom Software
Shares of Ryanair Holdings plc (RYAAY - Free Report) and Paycom Software, Inc. (PAYC - Free Report) have advanced 28.5% and 21.7% (versus the S&P 500’s 11.2% rise), respectively, since their Zacks Recommendation was upgraded to Outperform on April 15.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Stocks Palantir, Ulta Beauty Shoot Up
Shares of Palantir Technologies Inc. (PLTR - Free Report) , which belongs to the Zacks Focus List, have gained 50.4% over the past 12 weeks. The stock was added to the Focus List on March 26, 2024. Another Focus-List holding, Ulta Beauty, Inc. (ULTA - Free Report) , which was added to the portfolio on March 25, 2020, has returned 31% over the past 12 weeks. The S&P 500 has advanced 4.1% over this period.
The Focus List portfolio has returned -3.23% through April 30th, 2025, vs. -4.92% for the S&P 500 index and -2.88% for the equal-weight version of the index.
The 50-stock Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for the S&P 500 index and +13% for the equal-weight S&P 500 index. The portfolio had returned +29.54% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio returned -15.2% vs. the S&P 500 index’s -17.96%.
Since 2004, the Focus List portfolio has produced an annualized return of +11.33% (through the end of April 2025). This compares to a +9.95% annualized return for the S&P 500 index and +9.17% for the equal-weight version of the index in the same time period.
The portfolio lags the broader market over the preceding year (+10.74% vs. +12.12%), but leads over the preceding 3-year (+47.29% vs. +41.16%), 5-year (+122.94% vs. +106.51%), and 10-year (+225.28% vs. +219.55%) periods.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Monster Beverage & Oracle Make Significant Gains
Monster Beverage Corporation (MNST - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 15.1% over the past 12 weeks. Oracle Corporation (ORCL - Free Report) has followed Monster Beverage with 12.2% returns.
The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned +3.20% in the first quarter of 2025 vs. the S&P 500 index’s -4.30% decline (SPY ETF).
For the year 2024, the portfolio returned +16.26% vs. +24.89% for the S&P 500 index (SPY ETF).
In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.
With little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Zacks ECDP Stocks Intercontinental Exchange and Hormel Foods Outperform Peers
Intercontinental Exchange, Inc. (ICE - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 5% over the past 12 weeks. Another ECDP stock, Hormel Foods Corporation (HRL - Free Report) , has climbed 2.4% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.
With an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.
The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +5.74% in 2025 Q1 vs. the S&P 500 index’s -2.41% pullback and the Dividend Aristocrats ETF’s (NOBL) +3.11% return.
For the full-year 2024, the portfolio returned +6.95% vs. +24.89% for the S&P 500 index and +6.72% for NOBL.
The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.
Zacks Top 10 Stock Goldman Sachs Delivers Solid Returns
The Goldman Sachs Group, Inc. (GS - Free Report) , from the Zacks Top 10 Stocks for 2025, has jumped 7.2% year to date compared with the S&P 500 Index’s 2.3% increase.
The Top 10 portfolio returned -7.88% this year (through the end of April 2025) vs. -4.92% for the S&P 500 index and -2.88% for the equal-weight version of the index.
The Top 10 portfolio returned +62.98% in 2024, vs. +25.04% for the S&P 500 index and +13% for the equal-weight version of the index. The portfolio had returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.
Since 2012, the Top 10 portfolio has produced a cumulative return of +1832.3% through the end of April 2025 vs. +434.2% for the S&P 500 index and +338.6% for the equal-weight version of the index. The portfolio has produced an average return of +24.3% in the period 2012 through April
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus
Key Takeaways
Last Friday, the three most widely followed benchmark indexes closed a winning week. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite advanced 1.2%, 1.5% and 2.2%, respectively.
A stronger-than-expected May jobs report boosted investor confidence, pushing the S&P???500 above 6,000 for the first time since Feb. 21. Tech stocks led the charge, with Nvidia’s earnings shooting up 26% and Tesla recovering after a sharp fall linked to a public spat between Elon Musk and President Trump.
Broader optimism stemmed from easing U.S.-China trade tensions following presidential talks, helping global indices hit record highs. President Trump confirmed that he had had a very good phone call with President Xi and that trade negotiations would commence as early as this week. While tariff concerns continue to dominate proceedings, resilient data and upbeat earnings kept markets firmly in bullish territory.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Knightscope and Microbot Medical Surge Following Zacks Rank Upgrade
Shares of Knightscope, Inc. (KSCP - Free Report) have gained 142.1% (versus the S&P 500’s 20.7% increase) since it was upgraded to a Zacks Rank #2 (Buy) on April 9.
Another stock, Microbot Medical Inc. (MBOT - Free Report) , which was upgraded to a Zacks Rank #2 on April 11, has returned 57% (versus the S&P 500’s 14.2% increase) since then.
A hypothetical portfolio of Zacks Rank # 1 (Strong Buy) stocks returned -8.32% in 2025 (through May 5th) vs. -5.35% for the S&P 500 index.
This portfolio returned +22.4% in 2024, vs. +28% for the S&P 500 index and +19.9% for the equal-weight version of the S&P 500 index.
This hypothetical portfolio returned +20.65% in 2023 vs. +24.83% for the S&P 500 index and +15% for the equal-weight S&P 500 index.
The Zacks Model Portfolio - consisting of Zacks Rank #1 stocks – has outperformed the S&P index by more than 12 percentage points since 1988 (through May 5th, 2025, the Zacks # 1 Rank stocks generated an annualized average return of +23.5% vs. +11% for the S&P 500 index).
You can see the complete list of today’s Zacks Rank #1 stocks here >>>
Check Knightscope’s historical EPS and Sales here>>>
Check Microbot’s historical EPS and Sales here>>>
Image Source: Zacks Investment Research
Zacks Recommendation Upgrades Ryanair and Paycom Software
Shares of Ryanair Holdings plc (RYAAY - Free Report) and Paycom Software, Inc. (PAYC - Free Report) have advanced 28.5% and 21.7% (versus the S&P 500’s 11.2% rise), respectively, since their Zacks Recommendation was upgraded to Outperform on April 15.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Stocks Palantir, Ulta Beauty Shoot Up
Shares of Palantir Technologies Inc. (PLTR - Free Report) , which belongs to the Zacks Focus List, have gained 50.4% over the past 12 weeks. The stock was added to the Focus List on March 26, 2024. Another Focus-List holding, Ulta Beauty, Inc. (ULTA - Free Report) , which was added to the portfolio on March 25, 2020, has returned 31% over the past 12 weeks. The S&P 500 has advanced 4.1% over this period.
The Focus List portfolio has returned -3.23% through April 30th, 2025, vs. -4.92% for the S&P 500 index and -2.88% for the equal-weight version of the index.
The 50-stock Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for the S&P 500 index and +13% for the equal-weight S&P 500 index. The portfolio had returned +29.54% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio returned -15.2% vs. the S&P 500 index’s -17.96%.
Since 2004, the Focus List portfolio has produced an annualized return of +11.33% (through the end of April 2025). This compares to a +9.95% annualized return for the S&P 500 index and +9.17% for the equal-weight version of the index in the same time period.
The portfolio lags the broader market over the preceding year (+10.74% vs. +12.12%), but leads over the preceding 3-year (+47.29% vs. +41.16%), 5-year (+122.94% vs. +106.51%), and 10-year (+225.28% vs. +219.55%) periods.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Monster Beverage & Oracle Make Significant Gains
Monster Beverage Corporation (MNST - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 15.1% over the past 12 weeks. Oracle Corporation (ORCL - Free Report) has followed Monster Beverage with 12.2% returns.
The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned +3.20% in the first quarter of 2025 vs. the S&P 500 index’s -4.30% decline (SPY ETF).
For the year 2024, the portfolio returned +16.26% vs. +24.89% for the S&P 500 index (SPY ETF).
In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.
With little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Zacks ECDP Stocks Intercontinental Exchange and Hormel Foods Outperform Peers
Intercontinental Exchange, Inc. (ICE - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 5% over the past 12 weeks. Another ECDP stock, Hormel Foods Corporation (HRL - Free Report) , has climbed 2.4% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.
Check Intercontinental's dividend history here>>>
Check Hormel Foods’ dividend history here>>>
With an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.
The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +5.74% in 2025 Q1 vs. the S&P 500 index’s -2.41% pullback and the Dividend Aristocrats ETF’s (NOBL) +3.11% return.
For the full-year 2024, the portfolio returned +6.95% vs. +24.89% for the S&P 500 index and +6.72% for NOBL.
The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.
Click here to access this portfolio on Zacks Advisor Tools.
Zacks Top 10 Stock Goldman Sachs Delivers Solid Returns
The Goldman Sachs Group, Inc. (GS - Free Report) , from the Zacks Top 10 Stocks for 2025, has jumped 7.2% year to date compared with the S&P 500 Index’s 2.3% increase.
The Top 10 portfolio returned -7.88% this year (through the end of April 2025) vs. -4.92% for the S&P 500 index and -2.88% for the equal-weight version of the index.
The Top 10 portfolio returned +62.98% in 2024, vs. +25.04% for the S&P 500 index and +13% for the equal-weight version of the index. The portfolio had returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.
Since 2012, the Top 10 portfolio has produced a cumulative return of +1832.3% through the end of April 2025 vs. +434.2% for the S&P 500 index and +338.6% for the equal-weight version of the index. The portfolio has produced an average return of +24.3% in the period 2012 through April